Liando Investment
Overview
Beijing Liando Investment (Group) Co., Ltd., also known as Liando Group, is a group company that primarily focuses on operating and servicing industrial parks under its core brand 'Liando U Valley'. The company has a national presence, having developed and operated over 350 industrial parks in more than 70 cities across China, serving over 13,000 enterprises. In addition to its core business of industrial real estate, the group is an active investor. It makes direct equity investments in companies, such as its participation in the Series B funding for Megarobo. Liando also acts as a Limited Partner (LP), investing in several professional venture capital funds.
Portfolio Companies
6
Website
liando.cnInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lynk Pharmaceuticals | Sep 2023 | Series C Extension | Co-investor |
| Grit Biotherapeutics | Sep 2023 | Series B | Co-investor |
| Lynk Pharmaceuticals | May 2023 | Series C | Co-investor |
| 杭州慧医道科技有限公司 | Jul 2022 | Series B | Co-investor |
| 火石创造 | Jul 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
